Patent · US Active

Wound spray

US11116868B2 · kind B2 · utility

1Cited by

5References

15Claims

0Family size

Assignee

Mölnlycke Health Care AB · SE

Inventors

Michael Sander · Blankenloch, DE
Harald Potzschke · Wiesbaden, DE

Key dates

Filing date	Mar 31, 2020
Grant date	Sep 14, 2021
Priority date	—
Expiry date	Mar 31, 2040

Classification

Technology area (CPC F)Mechanical Engineering; Lighting; Heating
CPC primaryF04C2270/041
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.